A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
The aim of the trial is to optimize response rates and rates of secondary resections of
metastases in patients with initially non-resectable metastatic colorectal cancer Liver
Metastasis. The patients will be treated with systemic chemotherapy With irinotecan plus
hepatic arterial infusion With floxuridine and oxaliplatin